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Introduction: Depression in people living with HIV/AIDS is associated with poor health 
outcomes. Despite this, assessment of depressive symptoms is not a routine clinical 
practice in the care of people with HIV in Colombia. One reason could be the lack of 
validated depression screening scales for this population.
Objective: To test the reliability and construct validity of the 20- and 10-item-Center for 
Epidemiological Studies Depression Scale in patients attending an HIV clinic in Cali, 
Colombia. 
Materials and methods: A non-random sample of 105 adults was enrolled. The 20 item-
CES-D (CES-D-20) scale was administered twice: At baseline and 2-4 weeks later. We 
calculated the Cronbach’s alpha coefficient and the intraclass correlation coefficient. In 
addition, we used an exploratory and confirmatory factorial analysis, as well as the item 
response theory to assess the validity of the scale. 
Results: Most participants were men (73%), with a mean age of 40 years, 53% of whom 
had not completed high school. Cronbach’s coefficients were 0.92 and 0.94 at baseline and 
at the second interview, respectively. The intraclass correlation was 0.81 (95% CI: 0.72-
0.88). Although all 20 items loaded distinctly in 4 factors, 5 items did not load as expected. 
The structure factor of the CES-D-20 was not confirmed, as 4 items had poor goodness of 
fit. The CES-D-10 appeared to perform better in this population.
Conclusions: These results support the reliability and validity of the CES-D-10 instrument 
to screen for depressive symptoms in people living with HIV in Colombia.
Key words: Psychometrics; depression; reproducibility of results; HIV; acquired 
immunodeficiency syndrome; adult; Colombia.
Propiedades psicométricas y validez de la escala de depresión del Center for 
Epidemiological Studies (CES-D) en personas atendidas en una clínica de HIV en 
Cali, Colombia
Introducción. La depresión en personas con HIV/sida se asocia con resultados negativos 
para la salud. La evaluación de los síntomas depresivos no es una práctica clínica rutinaria 
en el cuidado de personas con HIV/sida en Colombia, lo cual puede deberse a la carencia de 
escalas validadas para la tamización de la depresión en esta población. 
Objetivo. Evaluar la reproducibilidad y validez de constructo de dos versiones de la escala 
de depresión del Center for Epidemiological Studies (CES-D), la de 20 ítems y la de 10 
ítems, en personas con HIV/sida atendidas en una clínica de Cali, Colombia.
Materiales y métodos. Se seleccionó una muestra no probabilística de 105 adultos con 
HIV/sida. La escala CES-D se utilizó dos veces (línea basal y 2 a 4 semanas después). La 
consistencia interna fue evaluada con el coeficiente alfa de Cronbach. La reproducibilidad se 
evaluó con el coeficiente de correlación intraclase. Para verificar la validez del constructo se 
utilizó un análisis factorial exploratorio y la teoría de respuesta al ítem. 
Resultados. El 73 % de la muestra correspondía a hombres, la edad promedio fue de 40 
años y el 53 % tenía baja escolaridad. El coeficiente alfa de Cronbach fue de 0,92 (línea 
basal) y de 0,94 (segunda entrevista). El coeficiente de correlación intraclase fue de 0,81 
(IC95% 0,72-0,88). Aunque en cuatro de los factores en la escala de 20 ítems claramente 
hubo carga factorial, cinco de los ítems no tuvieron un ajuste adecuado. La CES-D de 10 
ítems parece funcionar mejor en esta población. 
Conclusiones. Los resultados respaldaron la reproducibilidad y la validez de la escala CES-D 
para la tamización de síntomas depresivos en personas con HIV/sida en Colombia.
Palabras clave: psicometría; depresión; reproducibilidad de los resultados; VIH; síndrome 
de inmunodeficiencia adquirida; adulto; Colombia.
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Depression has emerged as a significant mental health issue worldwide 
(1-3), and people living with HIV/AIDS are not an exception. People living 
with HIV/AIDS are disproportionally affected by depression with a 5 to 10 
times higher prevalence than in the general population (4). In North America, 
approximately half of the people living with HIV/AIDS have significant 
depressive symptoms and 20 to 25% of them meet diagnostic criteria 
for a depressive disorder (5,6) while in low and middle-income countries 
depression among people living with HIV/AIDS ranges from 10% to 68% 
(7-10). Moreover, depression in people living with HIV/AIDS is a strong 
predictor of low levels of treatment adherence, poor virologic response, and 
increased risk of other chronic conditions (6,11). Depression is associated 
with increased HIV-specific morbidity and earlier mortality despite access to 
adequate antiretroviral therapy (12-14), and with overall lower quality of life as 
measured by a decreased concentration span, poor sleep quality, decreased 
memory, lower motivation, and increased stress (11,15-19). On this basis, the 
assessment and treatment of depression are essential in the care of people 
living with HIV/AIDS. Despite its importance, screening for depression is not 
consistently performed in the routine clinical care of people living with HIV/
AIDS in Colombia. This may be due in part to the lack of validated scales to 
screen for depression in this population.
The Depression Scale of the Center for Epidemiologic Studies (CES-D) is 
a widely used screening scale for depression which has been demonstrated 
to hold construct and concurrent validity in Colombian adolescents and 
adults (20-22). In the general population, the CES-D original cut-off point 
for depression was ≥16 points, although in Colombian populations a better 
trade-off of sensitivity and specificity was found to be ≥20 points (21). The 
reliability of the original English language scale had alpha coefficients ranging 
from 0.85 to 0.9 (20-23). In people living with HIV/AIDS, the CES-D preserved 
its validity in multiple settings (24-27). A cut-off point of ≥16 points has been 
found to have a sensitivity ranging from 72.7% to 79.8% and a specificity 
ranging from 78.5% to 83.0% in different studies (25-28). Shorter CES-D 
scales have also been validated with the 10-item version working as efficiently 
as the 20-item one (29).
However, inconsistent results have been found for somatic and positive 
affect items of the CES-D in people living with HIV/AIDS (30-32). This lack of 
consistency of the scale in several people living with HIV/AIDS populations 
emphasizes the need for its cross-cultural validation (33). Thus, we tested the 
reliability and construct validity of the 20-item and the 10-item versions of the 
CES-D (proposed by Zhang, et al.) (29).
Materials and methods
Study population
People living with HIV/AIDS followed in an HIV clinic in Cali (Corporación 
de Lucha contra el Sida) were invited to participate in a validation study 
of depression, stigma and adherence scales. The Corporación de Lucha 
contra el Sida clinic is a non-profit organization that provides comprehensive 
care to people living with HIV/AIDS in Cali and nearby cities in the south-
western part of Colombia. 
Participants were invited if they were 18 years of age or older, were 
able to provide informed consent, and could be on or off antiretroviral 
therapy. Potential participants were approached at the clinic during regular 
appointments and a non-random sample of participants was recruited. 
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One hundred and nine patients were invited to participate of whom 
105 accepted. All participants were asked to attend two visits, two to four 
weeks apart. Eighty-four of them completed the follow-up at 2 to 4 weeks. 
The sample size was calculated to obtain 60 participants in each of three 
groups: One group of participants naïve to antiretroviral therapy (ART), one 
with less than one year of ART, and the last one with participants with more 
than one year of ART. After 6 months of recruitment, we were unable to 
recruit participants to the first group and, thus, recruitment was halted before 
completing the sample of 180.
Data collection
An interviewer conducted face-to-face interviews with each participant. 
Interviews lasted from 30 minutes to an hour and took place at the 
Corporación de Lucha contra el Sida in a room that ensured privacy and 
confidentiality. The baseline questionnaire included data on age (years), sex 
at birth, sexual orientation (homosexual, bisexual, heterosexual), ethnicity, 
civil status (married/living with a partner or not), education level, work 
status, number of dependent children, level of satisfaction with the place 
of residence, history of incarceration, and lifestyle characteristics such as 
regular exercise, smoking, frequency of alcohol and drug use, sexual health 
(sexually active, condom use, etc.). In addition, clinical factors were extracted 
from the participants’ charts: The viral load and T lymphocyte subpopulation 
levels including CD4/CD8 ratios.
Center for Epidemiological Studies Depression Scale (CES-D)
The CES-D is a 20-item scale (23). Each item is scored on a 4-point scale 
ranging from 0 (rarely/none of the time) to 3 (most/all of the time). Scores on 
the CES-D range from 0 to 60 with greater scores indicating a greater degree 
of depressive symptoms. The scale is composed of four dimensions as per the 
original development: negative affect (items 3, 6, 9, 14, 17, and 18); positive 
affect (items 4, 8, 10, 12, and 16); somatic (items 1, 2, 5, 7, 11, and 20), and 
interpersonal (items 13, 15, and 19) manifestations of depressive illness. 
We used a Spanish translation of the CES-D scale that other authors had 
previously tested for validity and reliability in different populations (22,34). The 
cut-off points of 16 and 20 were used to define the presence of depression 
since previous studies have suggested that such thresholds were discerning 
for the presence of depression (21,22,24,25,27,34,35). It should be pointed that 
the 10-item version proposed by Zhang, et al. (29), has demonstrated to have a 
sensitivity of 91% and a specificity of 92%, with a cut-off of ≥10 in people living 
with HIV/AIDS. This version includes items 1, 5, 6, 7, 8, 10,11,12,14, and 20.
Ethical aspects
The participation in the study was voluntary. We obtained written informed 
consent from each participant. This study was reviewed and approved by the 
Research Ethics Boards of both the Corporación de Lucha contra el Sida and 
Queen’s University.
Statistical analyses
Descriptive statistics were used to summarise the social and clinical 
characteristics of the sample. The internal consistency reliability was tested 
using Cronbach’s coefficient. Test-retest reliability was assessed using the 
intraclass correlation coefficient. Construct validity was established using 
exploratory factorial analysis and confirmatory factor analysis. 
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n %
Age (years)
20-29 
30-39
40-49
≥50
Sex
Men
Educational level
None or primary
Secondary
Technical education
University (incomplete/complete)
No data
Employment status
Work
Housekeepers
Other
Unemployed
No data
Marital status
Single
Married/common law marriage
Widow, separated or divorced
No data
Life styles
Current smoker
Recreational drugs in the last three 
months (yes)
Any consumption of alcohol in the last 30 
days (yes)
Tattoos (yes)
Ever been arrested (yes)
Regular exercise or any physical activity 
3 or more times a week (yes)
17
33
40
15
76
38
38
14
13
2
32
11
22
37
3
66
26
11
2
24
12
44
28
22
43
16
31
38
14
72
37
36
13
13
2
30
10
21
35
3
63
25
11
2
23
11
42
27
21
43
Median
Interquartile 
range 
(Q25-Q75)
CD4 levels (cell/mm3)
Viral load (copies/ml)
CD8 levels (cell/mm3)
CD4/CD8 ratio
369
0
850
0.35
220-555
0-1303
574-1151
0.23-0.69
Table 1. Characteristics of people living with HIV/AIDS participating in the study (n=105) 
In interpreting the factor pattern, a factor loading ≥0.40 was considered 
good. In confirmatory factor analysis, model fit was defined as a 
comparative fit index and a Tucker-Lewis index of 0.95 while the root mean 
square error of approximation and the standardized root mean square 
residual were <0.08 (36). We further performed an item response theory 
analysis to establish items with poor fit and to identify the discriminative 
capacity of the CES-D items (37). 
Finally, we examined the construct validity of the scale by comparing 
social and clinical characteristics of those with 1) CES-D scores <16 with 
those with CES-D scores ≥16; 2) CES-D scores <20 with those with CES-D 
scores ≥20, and 3) those with ≥10 points in the shorten version vs <10 
points. Group comparisons were conducted using t-tests for continuous 
variables and contingency table chi-square tests for categorical data and the 
Mann-Whitney test. All analyses were done with Stata/IC version 12, and R, 
version 3.3.3.
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Results
The baseline demographic characteristics of the 105 participants are 
shown in table 1. Most participants were men (73%) with an average age of 
40 years (range: 21-71 years). Participants had low education levels, with 
73% not having completed high school. In addition, 63% reported being single 
and 35% unemployed.
Exploratory factor analysis and reliability
The Cronbach’s alpha coefficients for the CES-D-20 were 0.92 and 0.94 
for baseline and second interview, respectively, and these values did not 
change when excluding an item. The intraclass correlation coefficient was 
0.81 (95% CI: 0.72-0.88). Exploratory factorial analysis revealed four factors 
(table 2). The first factor explained 42.5% of the variance; the second, 
9%; the third, 7%, and the fourth, 5%. With the exception of item 2 (“I did 
not feel like eating, my appetite was poor”), all items loaded distinctly with 
factor loadings in the range of 0.50-0.80. Five items did not load in the 
same dimension as in the original scale: items 7, 11, and 20, which are 
somatic dimensions, item 12, related to positive affect, and item 13, related 
to interpersonal dimension. The Cronbach’s alpha was good for factor 1 but 
was <0.8 for the other three factors. The exploratory factor analysis for the 
CES-D-10 revealed that one factor explained 50% of the variance, and the 
second factor, 11%. The second factor only included item 8; the Cronbach’s 
alpha was 0.89 for the first factor with the nine items.
Table 2. Rotated factor loadings for 20- and 10-item CES-D scale versions (pattern matrix) 
(S): Somatic; (D): Depressed; (P): Positive, and (I) Interpersonal, as per original scale method: Principal-component factors; Rotation: Orthogonal 
varimax. Kaiser-Meyer-Olkin measure of sampling adequacy was 0.8630.
* Highest factor loading consistent with the highest factor loading in the original structure
CES-D 20 CES-D 10
Item Factor I Factor II Factor III Factor IV Factor I Factor II
1. I was bothered by things that do not usually bother me. (S) Me 
molestaron cosas que usualmente no me molestan
2. I did not feel like eating; my appetite was poor. (S) No me sentía con 
ganas de comer; tenía mal apetito.
3. I felt that I could not shake off the blues even with the help of my 
family and friends. (D) Me sentía que no podía quitarme de encima la 
tristeza, aun con la ayuda de mi familia o amigos.
4. I felt that I was just as good as other people. (P)  Sentía que yo era 
tan bueno(a) como cualquier otra persona.
5. I had trouble keeping my mind on what I was doing. (S) Tenía 
dificultad en concentrarme en lo que estaba haciendo.
6. I felt depressed. (D) Me sentía deprimido(a).
7. I felt that everything I did was an effort. (S) Sentía que todo lo que 
hacía era un esfuerzo.
8. I felt hopeful about the future. (P) Me sentía optimista sobre el futuro.
9. I thought my life had been a failure. (D)  Pensé que mi vida había sido 
un fracaso.
10. I felt fearful. (D) Me sentía con miedo.
11. My sleep was restless. (S) Mi sueño era inquieto.
12. I was happy. (P) Estaba contento(a).
13. I talked less than usual. (I) Hablaba menos de lo usual.
14. I felt lonely. (D) Me sentía solo(a).
15. People were unfriendly. (I) La gente no era amistosa.
16. I enjoyed life. (P) Disfrutaba de la vida.
17. I had crying spells. (D) Pasaba ratos llorando.
18. I felt sad. (D) Me sentía triste.
19. I felt that people disliked me. (I) Sentía que no le caía bien a la gente
20. I could not get going. (S) No tenía ganas de hacer nada.
Cronbach’s alpha
0.35
0.80*
0.85*
0.65
0.69*
0.79*
0.75
0.68
0.62*
0.61*
0.75*
0.55
0.93
0.80*
0.75*
0.50
0.75
0.62*
0.50*
0.79
0.64
0.85*
0.50*
0.64*
0.64
0.56
0.70
0.83
0.78
0.80
0.78
0.56
0.72
0.72
0.88
0.82
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Confirmatory factor analysis
Table 3 summarizes the model fit of statistics for different factor solutions. 
The best fit was obtained with the CES-D-10 scale, either with or without item 
8. The factor solution of the CES-D-20 of table 2 and the original scale factor 
solution did not meet the criteria for goodness to fit of the model (table 3).
Item response analysis
Four of the items of the CES-D-20 failed the test of fit (item-fit statistics 
for a multidimensional model). Poorly fitting items should be expected with 
the significance <0.05, to diagnose where the functional form of the item 
response theory analysis model was incorrectly specified: 3 (p=0.040), 6 
(p=0.038), 9 (p=0.036) and 13 (p=0.050). In the CES-D-10 scale, only item 
5 failed to demonstrate unacceptable fit (p=0.007). Items 4, 8, and 13 in the 
CES-D-20 and item 8 in the CES-D-10 did not show acceptable discrimination 
values (how well items identify patients at different levels of depression).
Correlates of depression
Of the participants, 54.3% (95% CI: 44.6-64.0) had CES-D scores of ≥16, 
44.8% (95% CI: 35.1-54.4) had CES-D scores of ≥20 with the 20 item scale, 
and 53.3% (95% CI: 43.6-63.0) had CES-D scores of ≥ 10 with the 10-item 
scale. The relationships between the exposure and the presence of depressive 
symptoms were consistent across the different cut-off points used (table 4). A 
score over the cut-off points (either ≥16 or ≥20 in the CES-D-20, or ≥10 in the 
CES-D-10) was more frequent among women, housewives, the unemployed, 
and among those with dissatisfaction regarding housing and those who did not 
exercise. When using the cut-off point of ≥16, we found an association with 
smoking which did not occur when using the other two cut-off points (table 
4). A higher viral load and lower CD4 levels were found in those with possible 
depression and this was consistent with all three CES-D versions (table 5).
Discussion
The adaptation and use of the CES-D scale were felt to be an important 
tool in the clinical assessment of people living with HIV/AIDS, a population 
with special social and clinical characteristics that differ from those of the 
general adult population in Colombia. Ours is the first study in Colombian 
people living with HIV/AIDS examining the validity and reliability of both the 
20 item and the 10 item versions of the CES-D scale. 
The application of this scale in our sample was straightforward and subjects 
were eager to answer all questions, which resulted in no missing data. 
The long scale demonstrated high internal reliability suggesting that the 
20 items measured the same underlying construct: depressive symptoms. It 
also showed a high construct validity as it correlated with known established 
Model
Original 
20-CES-D 
factor 
solution
Factor solution 
of table 2
Factor solution 
of table 2 
without item 2
CES-D 10 
one factor
Excluding 
item 8
CFI
TLI
SRMR
RMSEA
0.827
0.799
0.08
0.10
0.84
0.81
0.08
0.09
0.85
0.83
0.08
0.10
0.95
0.94
0.05
0.08
0.96
0.95
0.05
0.07
CFI Comparative fit index; TLI: Tucker-Lewis index; SRMR: Standardised root mean square residual; 
RMSEA: Root mean square error of approximation
Table 3. Confirmatory factor analysis of the CES-D 20 and CES-D 10 scales
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CES-D 
(20 items) 
scores <16
CES-D 
(20 items) 
scores ≥16
CES-D 
(20 items) 
scores <20
CES-D (20 
items) scores 
≥20
CES-D 
(10 items) 
scores <10
CES-D 
(10 items) 
scores ≥10
% % p-value % % p-value % % p-value
Gender
Female
Male
Educational level
None or primary
Secondary
Technical education
University
Employment status
Work
Housekeepers
Unemployed
Other
Marital status 
Single
Married /common law 
marriage/
Widow/separated or 
divorced
Dependent children
Yes
No
Currently lives with:
Alone
Relatives
Spouse or partner    
and/or sons
Friends/other
You are satisfied with the 
place where you live now
Yes
No
Currently lives in:
Own house/apartment
House/apartment in rent
Other
Sexual orientation
Heterosexual
MSM
Bisexual
Have you ever been arrested 
Yes
No
Regular exercise
Yes
No
Tobacco
Never
Former smoker
Current smoker
Recreative drugs in the last 
3 months
Yes
No
How often do you drink 
alcohol
Never
<4/5 drinks monthly
>4/5 drinks more than 
once a month
Sexually active
Yes
No
Condom usage
Not every time
Every time
24
54
39
53
43
54
53
9
32
82
45
54
36
43
51
64
43
52
38
 
53
30
43
54
33
43
55
42
41
48
60
38
43
70
33
50
46
44
60
29
48
44
25
52
76
46
61
47
57
46
47
91
68
18
55
46
64
57
49
36
57
48
63
47
70
57
46
67
57
45
58
59
52
40
62
57
30
67
50
54
56
40
71
52
56
75
48
0.006
0.640
 
< 0.001
 
0.593
0.392
0.535
 
0.04
 
0.58
 
0.509
 
0.546
 0.025
0.032
0.772
0.126
0.655
 
0.156
 
31
64
45
61
57
62
63
18
43
82
55
58
45
52
57
64
52
62
38
61
37
55
56
33
52
59
50
59
53
70
45
50
70
50
67
52
51
67
43
56
51
25
61
69
36
55
39
43
38
38
82
57
18
45
42
55
48
43
36
48
38
62
39
63
45
44
67
48
41
50
41
47
30
55
50
30
50
33
48
49
33
57
44
49
75
39
 
0.002
0.510
 
 
0.002
 
 
0.791
 
 
0.590
0.598
0.035
0.565
0.825
0.616
0.013
 
0.252
0.346
 
0.238
0.602
 
0.055
 
28
54
37
50
64
54
66
9
35
64
45
58
36
43
53
45
46
57
38
53
33
45
49
67
43
55
50
50
47
60
40
46
57
42
58
47
42
60
43
47
49
25
50
72
46
63
50
36
46
34
91
65
36
55
42
64
57
47
55
54
43
63
47
67
55
51
33
57
45
50
50
53
40
60
54
43
58
42
53
58
40
57
53
51
75
50
0.015
0.306
0.002
0.419
0.288
0.759
0.085
0.579
0.525
0.797
0.039
0.576
0.447
0.270
0.842
0.186
Table 4. General characteristics of participants according to CES-D scores
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factors for depression, such as gender, low socio-economic status, and 
smoking. However, our factor analysis showed that 5 of the 20 items did 
not load in the original scale factor loadings. Similar findings have been 
reported in previous validation studies in which the original four dimensions 
in the CES-D scale did not hold for people living with HIV/AIDS (37). Our 
factor analysis failed to confirm the model fit in the factor solution of the 
20 item version, and the item response theory analysis established that 
four items did not meet the criteria for a good fit. Thus, the usefulness 
of the total score of the CES-D in people living with HIV/AIDS should be 
approached with caution. In contrast, the CES-D-10 appeared to work better 
in our sample population as it showed high internal consistency and a valid 
factorial structure. The usefulness of this shorter CES-D scale has also 
been found by other studies (38).
It has been documented that the CES-D scale has a factorial structure 
that behaves inconsistently in different populations including people living 
with HIV/AIDS (25,31,37). Some authors have found a different factorial 
structure when using the oblique rotation (24). We found that the oblique 
rotation was no better than that obtained with varimax (data not shown). In 
a clinical sample of 350 people living with HIV/AIDS, Gay, et al. (37) found 
that items 2, 4, 8, 11, and 16, which are mostly related to positive affect, were 
problematic and caused the scale to lose validity. In our study, we found that 
item 8 was also problematic. Some authors have even recommended to fully 
exclude positive affect items from the CES-D (31,39). Furthermore, we found 
four different items with poor fit: items 3, 6, 9, and 13, which mainly relate to 
depressive state and seem to load differently according to other reports (40). 
Since the CES-D-10 scale did not include items 3, 9 and 13, this may explain 
why in our population it held its validity.
It has been suggested that the somatic symptoms among HIV positive 
participants are difficult to interpret as they may overlap with medication side 
effects or with the effects of HIV infection itself (30). Other studies have found 
that those items are more likely to load in different factors (41). In fact, four of 
the items that did not load in the same factor as the original scale in our sample 
were related to somatic symptoms (items 2, 7, 11, and 20). Interestingly, items 
7, 11, and 20 loaded well on the CES-D-10 scale. Even shorter versions of the 
scale have been found to be valid in general populations (22). One version 
has seven items of which five are also included in the CES-D-10 that we 
studied. Thus, it is possible that somatic symptoms are not as problematic in 
populations of people living with HIV/AIDS in Colombia.
There was a high frequency of depressive symptoms in our sample 
and we found that social factors such as gender, housing satisfaction, 
unemployment, as well as smoking, were associated with more depressive 
CES-D (20 items) 
scores <16
CES-D (20 items) 
scores ≥ 16
CES-D (20 items) 
scores <20
CES-D (20 items) 
scores ≥20
CES-D (10 items) 
scores <10
CES-D (10 items) 
scores ≥10
Median 
(range IQ)
Median 
(range IQ) p
Median 
(range IQ)
Median 
(range IQ) p
Median 
(range IQ)
Median 
(range IQ) p
Age
CD4
Viral load
CD8
CD4/CD8
ratio
39.5 (30-46)
425 (319-591)
0 (0-675564)
925 (678-1162)
0.489 (0.287-0.657)
40 (34-45)
324.5 (189-458)
58.5 (0-21412)
766.5 (537-1113)
0.323 (0.213-0.712)
0.5914
0.0206
0.0373
0.0835
0.1922
39 (30-46)
423 (304-589)
0 (0-328)
918 (636-1289)
0.457 (0.280-0.657)
41 (34-46)
316 (189-434)
114 (0-21412)
755 (537-1078)
0.327 (0.213-0.712)
0.5551
0.0229
0.0221
0.0497
0.3285
 
 
39 (30-45)
434 (322-589)
0 (0-66)
939 (652-1289)
0.518 (0.280-0.657)
41 (34-47)
316 (189-440)
95 (0-21412)
778 (540-1107)
0.327 (0.213-0.712)
0.1476
0.0137
0.0066
0.0772
0.1824
Table 5. Immunology and virology distributions by CES-D scores
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symptoms in our sample. In addition, 60% of the women had high levels of 
depressive symptoms, which is consistent with a disproportionate prevalence 
of depression found in females living with HIV/AIDS in other studies 
(14,42,43) which suggest that the combination of depression with poverty, 
interpersonal violence, and the burden of caring for themselves and others 
creates numerous social challenges for women living with HIV (14,44,45). 
In this regard, it is conceivable that the ‘caregiver’ role that many 
Colombian women play (household tasks and raising children) can result in a 
high burden of stressful experiences (46,47). The coexistence of depression 
and smoking is well established in people living with HIV (48,49) which calls 
for interventions to address both conditions simultaneously. Studies have 
documented the association between disease severity as measured by CD4 
counts and depressive symptoms (14,50) an aspect that was also evidenced 
in the small sample of people living with HIV/AIDS under study.
We have not validated the CES-D against gold standards for the diagnosis 
of depressive disorders. A previous study in Colombia found that the 
20-point cut-off in the CES-D scale was better for depression in the general 
population; future studies in the country should consider confirming the factor 
structure and fit of the CES-D-20 scale with a more advanced item response 
theory analysis (51) and assess the accuracy of the full and shortened 
versions of this scale in people living with HIV/AIDS. Oversampling of women 
and transgender populations should be considered in those previous studies 
since one of them showed differences in item functions in those populations 
(37). Our sample size limited the possibility of assessing differences in item 
responses in such populations.
The CES-D scale has been extensively used worldwide and will likely 
continue to be used in future assessments of depressive symptoms 
in people living with HIV/AIDS. The subjective nature of this scale for 
the assessment of depressive symptoms may have resulted in an 
underestimation of the prevalence of depression due to social desirability 
bias. However, we believe that overestimation is more likely to occur than 
lack of validity in people living with HIV/AIDS given the lack of fit of some of 
the items reported. However, even with such overestimation, the CES-D-10 
scale can be a valid tool for the screening of depression and its use may 
effectively help select people living with HIV/AIDS who need a more 
detailed assessment and, eventually, treatment for depression.
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Appendix: Spanish version of the CES-D scale used in the study
Instrucciones: Las siguientes son preguntas relacionadas con su estado de ánimo. Hay una lista de 
maneras en la que usted pudo haberse sentido o comportado en la última semana. Por favor, indique con 
qué frecuencia se sintió de esta manera.
Durante la semana pasada…
Raramente o 
ninguna vez
(<1 día)
Una parte o un 
poco de tiempo
(1-2 días)
Ocasionalmente 
o una cantidad 
moderada de 
tiempo (3-4 días)
La mayoría o 
todo el tiempo
(5-7 días)
1. Me molestaron cosas que usualmente no 
me molestan.
2. No me sentía con ganas de comer; tenía 
mal apetito.
3. Me sentía que no podía quitarme de 
encima la tristeza, aun con la ayuda de mi 
familia o amigos.
4. Sentía que yo era tan bueno(a) como 
cualquier otra persona.
5. Tenía dificultades en concentrarme en lo 
que estaba haciendo.
6. Me sentía deprimido(a).
7. Sentía que todo lo que hacía era un 
esfuerzo.
8. Me sentía optimista sobre el futuro.
9. Pensé que mi vida había sido un fracaso.
10. Me sentía con miedo.
11. Mi sueño era inquieto.
12. Estaba contento(a).
13. Hablaba menos de lo usual.
14. Me sentía solo(a).
15. La gente no era amistosa.
16. Disfrutaba de la vida.
17. Pasaba ratos llorando.
18. Me sentía triste.
19. Sentía que no le caía bien a la gente.
20. No tenía ganas de hacer nada.
